Dupilumab: tested on its own
118 studies: no other medicine in its arm. Page 1 of 2. Open to participants first (21), then studies with results posted, then the rest; newest registration first within each.
- Dupilumab in Major Depressive DisorderRecruitingNCT07908563Phase 2Report a problem
- A Study to Investigate Dupixent/ Dupilumab in Adult Indian Participants With Moderate-to-severe Atopic DermatitisNot yet recruitingNCT07905547Phase 4Report a problem
- This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring HospitalizationRecruitingNCT07587658Phase 4Report a problem
- Complete Remission After Treatment With Biologics for Nasal PolypsRecruitingNCT07268313Phase 4Report a problem
- A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic EsophagitisRecruitingNCT07112378Phase 3Report a problem
- A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.RecruitingNCT07053423Phase 4Report a problem
- Immunologic Impact of Dupilumab in Patients Suffering From Asthma and Chronic Rhinosinusitis With PolypsNot yet recruitingNCT06556264Phase 4Report a problem
- Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic AgentsRecruitingNCT06477653Phase 2Report a problem
- A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo NodularisRecruitingNCT06293053Phase 3Report a problem
- Dupixent in Adults With Refractory Post-Burn Pruritus in an Ambulatory ClinicRecruitingNCT06226610Phase 2Report a problem
- Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)Enrolling by invitationNCT06191315Phase 3Report a problem
- Dupilumab in the Treatment of Pediatric Alopecia AreataRecruitingNCT05866562Phase 2Report a problem
- Molecular Signatures of Cutaneous Dupilumab ResponseRecruitingNCT05858619Phase 4Report a problem
- Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin DisordersRecruitingNCT05649098Early Phase 1Report a problem
- Regeneron AA Multicenter (Dupilumab)RecruitingNCT05551793Phase 2Report a problem
- Ethnic Differences in Mechanisms of Action of DupilumabRecruitingNCT05268107Phase 4Report a problem
- Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNPRecruitingNCT05094570Phase 4Report a problem
- Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic DermatitisRecruitingNCT05042258Phase 4Report a problem
- Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe AsthmaRecruitingNCT04743791Phase 4Report a problem
- Viral Infection in Asthma (VIA) StudyRecruitingNCT04380038Phase 4Report a problem
- Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)RecruitingNCT04296864Phase 2Report a problem
- Mechanisms of Smell Improvement With Dupilumab.CompletedNCT05964465Phase 4Results postedReport a problem
- Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema TrialCompletedNCT05590585Phase 4Results postedReport a problem
- Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory DiseaseActive, not recruitingNCT05575037Phase 2Results postedReport a problem
- A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥2 Years to <12 Years of Age With Uncontrolled Chronic Spontaneous Urticaria (CSU) (LIBERTY-CSU CUPIDKids)CompletedNCT05526521Phase 3Results postedReport a problem
- Study to Assess Efficacy and Safety of Dupilumab in the Treatment of KeloidsCompletedNCT05128383Phase 2Results postedReport a problem
- Dupilumab in Japanese Patients With Chronic Rhinosinusitis With Nasal Polyp (SINUS-M52)CompletedNCT05049122Phase 4Results postedReport a problem
- Effects of Interleukin (IL)- 4R-alpha Inhibition on Respiratory Microbiome and Immunologic Correlates in Severe AsthmaCompletedNCT05036733Phase 4Results postedReport a problem
- Safety and Efficacy of Dupilumab for Treatment of Hospitalized COVID-19 PatientsCompletedNCT04920916Phase 2Results postedReport a problem
- Dupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic DermatitisCompletedNCT04823130Phase 4Results postedReport a problem
- Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic DermatitisCompletedNCT04718870Phase 4Results postedReport a problem
- Dupilumab in Allergic Fungal Rhinosinusitis (AFRS)CompletedNCT04684524Phase 3Results postedReport a problem
- Dupilumab in CRSsNPCompletedNCT04678856Phase 2Results postedReport a problem
- A Phase 4, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Persistent AsthmaCompletedNCT04502862Phase 4Results postedReport a problem
- Dupilumab Skin Barrier Function Study in Atopic DermatitisCompletedNCT04447417Phase 4Results postedReport a problem
- Investigating Treatment With Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED)CompletedNCT04442269Phase 2Results postedReport a problem
- A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT)CompletedNCT04417894Phase 3Results postedReport a problem
- The Effect of Dupilumab on Lung Inflammation and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe AsthmaCompletedNCT04400318Phase 4Results postedReport a problem
- Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)CompletedNCT04394351Phase 3Results postedReport a problem
- Dupilumab for the Treatment of Moderate to Severe Chronic Hepatic PruritusCompletedNCT04256759Phase 2Results postedReport a problem
- A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With AsthmaCompletedNCT04203797Phase 4Results postedReport a problem
- Dupilumab and Milk OIT for the Treatment of Cow's Milk AllergyTerminatedNCT04148352Phase 2Results postedReport a problem
- SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"CompletedNCT04033367Phase 4Results postedReport a problem
- The Effects of Dupilumab on Allergic Contact DermatitisActive, not recruitingNCT03935971Phase 4Results postedReport a problem
- Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate CancerTerminatedNCT03886493Phase 2Results postedReport a problem
- Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut AllergyCompletedNCT03793608Phase 2Results postedReport a problem
- Dupilumab in Eosinophilic GastritisCompletedNCT03678545Phase 2Results postedReport a problem
- The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis PatientsCompletedNCT03667014Phase 4Results postedReport a problem
- Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE)CompletedNCT03633617Phase 3Results postedReport a problem
- Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up)CompletedNCT03620747Phase 3Results postedReport a problem
- Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic DermatitisTerminatedNCT03389893Phase 4Results postedReport a problem
- Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)CompletedNCT03359356Phase 2Results postedReport a problem
- Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL)CompletedNCT03346434Phase 2/3Results postedReport a problem
- Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)CompletedNCT03345914Phase 3Results postedReport a problem
- Immunogenetic Profiling of Dupilumab for the Treatment of Atopic DermatitisCompletedNCT03293030Phase 4Results postedReport a problem
- Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic DermatitisCompletedNCT03054428Phase 3Results postedReport a problem
- A Study to Assess the Efficacy and Safety of Dupilumab in Participants With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA Because it is Not Medically AdvisableCompletedNCT02755649Phase 3Results postedReport a problem
- A Study to Determine the Safety and Tolerability of Dupilumab (REGN668/SAR231893) in Patients Aged ≥6 to <18 Years With Atopic Dermatitis (Eczema)CompletedNCT02407756Phase 2Results postedReport a problem
- A Study to Confirm the Efficacy and Safety of Different Dupilumab Dose Regimens in Adults With Atopic Dermatitis (AD)CompletedNCT02395133Phase 3Results postedReport a problem
- Study of Dupilumab in Adult Participants With Active Eosinophilic Esophagitis (EoE)CompletedNCT02379052Phase 2Results postedReport a problem
- Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic DermatitisCompletedNCT02277769Phase 3Results postedReport a problem
- Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic DermatitisCompletedNCT02277743Phase 3Results postedReport a problem
- Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT02260986Phase 3Results postedReport a problem
- Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD)CompletedNCT02210780Phase 2Results postedReport a problem
- Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE)CompletedNCT02134028Phase 3Results postedReport a problem
- Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)CompletedNCT01979016Phase 2Results postedReport a problem
- Open-label Study of Dupilumab in Patients With Atopic DermatitisCompletedNCT01949311Phase 3Results postedReport a problem
- Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic DermatitisCompletedNCT01859988Phase 2Results postedReport a problem
- Study to Assess the Safety of Dupilumab (REGN668/SAR231893) Administered Concomitantly With Topical Corticosteroids (TCS) in Patients With Moderate-to-severe Atopic Dermatitis (AD)CompletedNCT01639040Phase 2Results postedReport a problem
- Study of Dupilumab in Adult Patients With Extrinsic Moderate-to-Severe Atopic DermatitisCompletedNCT01548404Phase 2Results postedReport a problem
- Study of Growth and Bone Mineral Density in Children With Atopic Dermatitis (AD) Treated With DupilumabWithdrawnNCT07187089Phase 4Report a problem
- Dupixent Study for Alternate AdministrationActive, not recruitingNCT06750471Phase 4Report a problem
- A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 2)CompletedNCT06687980Phase 3Report a problem
- A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 1)CompletedNCT06687967Phase 3Report a problem
- Study of Dupilumab 300 mg Every Other Week After Endoscopic Sinus Surgery in Patients With Allergic Fungal Rhinosinusitis (AFRS) on a Background Therapy With Intranasal Corticosteroid SprayWithdrawnNCT06461949Phase 3Report a problem
- Dupilumab for Eosinophilic Esophagitis With Severe StricturesActive, not recruitingNCT06352073Phase 4Report a problem
- Early-onset Dupilumab Effects in CRSwNPWithdrawnNCT06188871Phase 4Report a problem
- Dupilumab De-escalation in Pediatric Atopic DermatitisTerminatedNCT06116526Phase 4Report a problem
- A Study Assessing Esophageal Function and Remodeling With Dupilumab Compared With Placebo for 24 Weeks Followed by 104 Weeks Open Label in Adult Participants With EoE (REMOdeling With Dupilumab in Eosinophilic Esophagitis Long-term Trial)Active, not recruitingNCT06101095Phase 4Report a problem
- The Immunologic Effects of Dupilumab in the Treatment of Dermal Hypersensitivity ReactionCompletedNCT06012448Phase 4Report a problem
- DUPIlumab Dose REDUCtion in Patients With Controlled Atopic EczemaActive, not recruitingNCT06004986Phase 4Report a problem
- A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic DermatitisActive, not recruitingNCT05983068Phase 4Report a problem
- Single Dose Comparability Study of New and Current Dupilumab Drug Products Subcutaneously Administered in Healthy AdultsCompletedNCT05976386Phase 1Report a problem
- A Study to Investigate the Pharmacokinetics (PK), Tolerability and Safety of Two Different Dupilumab Drug Products in Healthy Participants.CompletedNCT05976373Phase 1Report a problem
- A Study to Investigate the Pharmacokinetics, Tolerability and Safety of Two Different Dupilumab Drug Products in Healthy ParticipantsCompletedNCT05976360Phase 1Report a problem
- A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May HaveActive, not recruitingNCT05831176Phase 2Report a problem
- A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab))Active, not recruitingNCT05731128Phase 2Report a problem
- Dupilumab Effects Against Aeroallergen ChallengeActive, not recruitingNCT05720325Phase 2Report a problem
- Dupilumab-pediatric Skin Barrier Function and Lipidomics Study in Patients With Atopic Dermatitis in ChinaCompletedNCT05680298Phase 4Report a problem
- Dupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in ChinaCompletedNCT05624112Phase 4Report a problem
- IL-4 and Insulin Resistance for Treatment of Patients With Atopic DermatitisCompletedNCT05372003Early Phase 1Report a problem
- Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and AdolescentsActive, not recruitingNCT05347771Phase 2Report a problem
- Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging.Status unknownNCT05265234Phase 4Report a problem
- Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe AsthmaActive, not recruitingNCT05097287Phase 4Report a problem
- Mechanisms of Dupilumab in AERDCompletedNCT05031455Phase 2Report a problem
- Dupilumab in the Treatment of KeloidsCompletedNCT04988022Phase 4Report a problem
- Dupilumab in Japanese Patients With Atopic DermatitisCompletedNCT04678882Phase 3Report a problem
- An Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic DermatitisStatus unknownNCT04520308Phase 4Report a problem
- Dupilumab in Severe Chronic Hand EczemaStatus unknownNCT04512339Phase 2Report a problem
- Effect of Dupilumab on Aspirin IntoleranceStatus unknownNCT04442256Phase 4Report a problem